Advaxis Says FDA Grants Fast Track Designation For ADXS-HER 2

By: via Benzinga
Advaxis, Inc. (NASDAQ: ADXS) revealed the Food and Drug Administration has given a Fast Track Designation for its immunotherapy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.